This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nguyen, K. T.
Right arrow Articles by Clancy, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, K. T.
Right arrow Articles by Clancy, C. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2009, p. 3347-3352, Vol. 53, No. 8
0066-4804/09/$08.00+0     doi:10.1128/AAC.01480-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Anidulafungin Is Fungicidal and Exerts a Variety of Postantifungal Effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates{triangledown}

Katherine T. Nguyen,1 Philip Ta,1 Bich Thu Hoang,1 Shaoji Cheng,1,4 Binghua Hao,1,4 M. Hong Nguyen,1,2,3,4 and Cornelius J. Clancy1,3,4,5*

Departments of Medicine,1 Molecular Genetics and Microbiology, University of Florida College of Medicine,2 the North Florida/South Georgia Veterans Health System, Gainesville, Florida,3 the Department of Medicine, University of Pittsburgh,4 the V.A. Pittsburgh Healthcare System, Pittsburgh, Pennsylvania5

Received 5 November 2008/ Returned for modification 2 February 2009/ Accepted 3 April 2009

Anidulafungin targets the cell walls of Candida species by inhibiting β-1,3-glucan synthase, thereby killing isolates and exerting prolonged postantifungal effects (PAFEs). We performed time-kill and PAFE experiments on Candida albicans (n = 4), C. glabrata (n = 3), C. parapsilosis (n = 3), and C. krusei (n = 2) isolates and characterized the PAFEs in greater detail. MICs were 0.008 to 0.125 µg/ml against C. albicans, C. glabrata, and C. krusei and 1.0 to 2.0 µg/ml against C. parapsilosis. During time-kill experiments, anidulafungin caused significant kills at 16x MIC (range, log 2.68 to 3.89) and 4x MIC (log 1.87 to 3.19), achieving fungicidal levels (≥log 3) against nine isolates. A 1-hour drug exposure during PAFE experiments resulted in kills ranging from log 1.55 to 3.47 and log 1.18 to 2.89 (16x and 4x MIC, respectively), achieving fungicidal levels against four isolates. Regrowth of all 12 isolates was inhibited for ≥12 h after drug washout. Isolates of each species collected 8 h after a 1-hour exposure to anidulafungin (16x and 4x MIC) were hypersusceptible to sodium dodecyl sulfate (0.01 to 0.04%) and calcofluor white (40 µg/ml). Moreover, PAFEs were associated with major cell wall disturbances, as evident in electron micrographs of viable cells, and significant reductions in adherence to buccal epithelial cells (P ≤ 0.01). Finally, three of four PAFE isolates tested were hypersusceptible to killing by J774 macrophages (P ≤ 0.007). Our data suggest that the efficacy of anidulafungin in the treatment of candidiasis might stem from both direct fungicidal activity and indirect PAFEs that lessen the ability of Candida cells to establish invasive disease and to persist within infected hosts.


* Corresponding author. Present address: University of Pittsburgh, 867 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261. Phone: (412) 624-0309. Fax: (412) 648-8455. E-mail: cjc76{at}pitt.edu

{triangledown} Published ahead of print on 13 April 2009.


Antimicrobial Agents and Chemotherapy, August 2009, p. 3347-3352, Vol. 53, No. 8
0066-4804/09/$08.00+0     doi:10.1128/AAC.01480-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.